Eden Research PLC has announced the appointment of Humair Tariq as the new Global Commercial Lead. Tariq, who brings extensive experience in the crop protection industry, will be responsible for leading the company's commercial efforts, fostering existing partnerships, developing new relationships, and driving revenue growth. His appointment reflects the company's commitment to expanding its team's resources and capabilities, supported by a stronger balance sheet and increasing revenue streams.

Tariq's background includes working for Syngenta as Portfolio Manager for biologicals, seed treatment, and insect control, and he holds an MBA degree with a focus on marketing. Sean Smith, Chief Executive Officer of Eden Research, expressed his pleasure in welcoming Tariq to the team, highlighting his industry experience and expertise. The company's focus on growth and the creation of long-term value for partners and shareholders is evident in this strategic appointment.

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture, developing and supplying innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health, and consumer products industries. The company's products are formulated with terpene active ingredients, based on natural plant defense metabolites, and have shown equal or better performance compared to conventional pesticides.

The company's current products on the market include Mevalone®, a foliar biofungicide targeting a key disease affecting grapes and other high-value fruit and vegetable crops, Cedroz™, a bionematicide targeting free-living nematodes affecting various crops, and Ecovelex, a seed treatment product designed to tackle crop destruction caused by birds. Additionally, Eden's Sustaine® encapsulation technology, which is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants, is one of the only viable, proven, and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden Research, which was awarded the London Stock Exchange Green Economy Mark in January 2021, derives 100% of its total annual revenues from sustainable products and services. The company was admitted to trading on AIM in May 2012 and trades under the symbol EDEN. For more information about Eden, visit their website at www.edenresearch.com.